News

July issue of Cyclodextrin News

News 1 August, 2017
July issue of Cyclodextrin News has been uploaded to our website. The editorial is now on "Cholesterol-binding Cyclodextins for the Treatment of Cystic Fibrosis and Other Diseases with Pulmonary Surfactant Dysfunction”. View the current issue here.
more

Abstract submission to 19th ICS started

News 31 July, 2017
Abstracts can be uploaded to the website of the 19th International Cyclodextrin Symposium from August 1 to September 16 using the template provided by the organizers.
more

3D printed nanomachines based on cyclodextrins

News 31 July, 2017
Science Daily and other scientific internet portals reported on novel nanomachines able to convert chemical energy into mechanical work (lifting a coin) through solvent exchange.
more

New product lines at CycloLab

News 19 July, 2017
As part of our new approach to application of CDs, we would like to draw your attention to a few derivatives and groups of products that have never been promoted before.
more

CycloLab pipeline project

News 19 July, 2017
In order to have a better understanding of investors and partners on the status and potential of the ongoing projects, we have prepared a few slides for the following:
more

New national project

News 13 July, 2017
Cyclodextrin-based traps to control cooperative action of bacteria.
more

Sucampo has aquired Vtesse

News 5 July, 2017
Sucampo Pharmaceuticals Inc., a global biopharmaceutical company has aquired Vtesse, rare disease company.
more

CD-based Water Cleaning Technology in Nature

News 5 July, 2017
Recent Nature (546/7657, published on 8 June 2017) reported on the novel CD-based sorbents for the removal of perfluorooctanoic acid (PFOA) from water.
more

The current issue of Cyclodextrin News is available.

News 14 June, 2017
Please observe that this issue has been compiled in a novel format.
more

Global Sulfobutyl Ether Beta-Cyclodextrin Market Research Report 2017

News 7 June, 2017
The market report focusing on the North American, European and Asia-Pacific regions gives forecast to 2021 on the world’s major market conditions.
more

Golf ball with CD-based rotaxane

News 7 June, 2017
A recently published US patent discloses a strange application of CDs: coating of golf balls with a mixture of polyurethane and CD-based polyrotaxane to provide excellent spin performance under wet conditions.
more

New CycloLab product list

News 10 May, 2017
CycloLab is delighted to present the freshly established product list that contains an even wider range of products than presented on the website and some clarification on the nature and uses of members in each product category. The full list is available to download as a pdf here.
more

April issue of Cyclodextrin News

News 8 May, 2017
April issue of Cyclodextrin News has been uploaded to our website. The editorial is now on " Cyclodextrin-assisted reconstitution of membrane proteins”.

View the current issue here.
more

CycloLab in the top 12 Manufacturers of Cyclodextrins

News 31 January, 2017
Worldwide Cyclodextrin Market Analysis and Forecasts 2017 has been compiled and now available. This report studies Cyclodextrin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer.
more

Clinical Study of HPBCD in Patients with NPC Disease at Karolinska University Hospital

News 21 December, 2016
CTD Holdings, Inc. received the approval of Swedish Medical products Agency to conduct a Phase I/II clinical trial evaluating intravenous application of Trappsol® Cyclo™ in patients with Niemann Pick type C (NPC) disease, a rare and fatal illness manifested in neurodegenerative, genetic lisosomal lipid metabolism disorder [1]. In addition to this Phase I/II study is being conducted in Europe, a US Phase I study will be started soon. The first patients are expected to be enrolled in the first quarter of 2017.
more

Re-evaluation of β-cyclodextrin (E 459) as a food additive

News 21 December, 2016
The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) re-evaluated β-cyclodextrin (E 459) as a food additive. The Panel concluded that, based on the available toxicological database, there is no reason to revise the current ADI of 5 mg/kg bw per day for β-cyclodextrin.
 
http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4628/full
more

Culture of Chemistry

News 30 November, 2016
The book includes specially selected articles that previously appeared in The Chemical Intelligencer magazine published in the period of 1995–2000 [1]. Excerpts of these Editor's choice chapters chronicle the culture and history of chemistry, featuring great chemists and discoverers.
more

With the help of cyclodextrins NASA prepares for first-ever in-space DNA sequencing experiment

News 30 November, 2016
Minion developed by Oxford Nanopore arrived to the international orbiting lab to start with the first-ever in-space DNA sequencer experiment. The MinION is a handheld device that weighs 120 g.
more

Special Issue on Cyclodextrins

News 4 November, 2016
International Journal of Pharmaceutics will publish a special issue on cyclodextrins and cyclodextrin derivatives in drug development. This issue will contain reviews and original scientific papers that are focused on Professor Duchêne’s
more

Study on Captisol Enabled Melphalan

News 12 October, 2016
The purpose of this study is to determine if the investigators can achieve a certain level of Captisol Enabled Melphalan that would be best to use in treating Multiple Myeloma and AL Amyloidosis. It is in the recruiting phase.
more

3rd CYCLON-HIT Summer School

News 12 October, 2016
The 3rd CYCLON-HIT Summer School dedicated to „Photoactivable antbacterials: from basic concept to practical approaches” has been recently held in Bologna (September 26–28, 2016). The school organiozed by Ilse Manet (ISOF-CNR) and Salvatore Sortino (University of Catania) teaches the photophysical and photochemical principles and gives several examples of cyclodextrin applications in photodynamic therapy. The final program can be seen here:
more

Alpha-CD tablets for animals

News 1 August, 2016
The recently marketed veterinary formulation is useful for improving the digestion of cats and dogs.
more

ENCAPSULATONS - New book from Academic Press

News 1 August, 2016
Volume 2 in the series of "Nanotechnology in the Agri-food Industry” with the title "Encapsulations” (edited by A.M. Grumezescu) has been recently published. It contains several chapters on cyclodextrin complexation of flavors and aromas.
more

György Kéri passed away

News 26 July, 2016
The world-wide recognized biochemist, Professor of Semmelweis University, György Kéri (66) passed away on 20th July after a long fight against an incurable disease. His outstanding research in the field of cell signaling therapy and related pharmaceuticals made him famous among professionals
more

Global and Chinese Cyclodextrin Industry – 2016

News 15 July, 2016
Several professional and in-depth studies on the current state of various cyclodextrin industries with a focus on the Chinese market can be purchased from Reports Express. The following market research reports are available:
more

18ICS finished with success

News 15 June, 2016
With about 80 participants from 15 countries the 18th International Cyclodextrin Symposium held on 18-21 May in Gainesville, USA was concluded with success.
more

Internet web site on cyclodextrins

News 2 May, 2016
Ars Technica, web site on technology news (founded in Cambridge, Massachussetts) has published a paper on the latest findings of cyclodextrins on atherosceloris with the title: “Sweet drug clears cholesterol, reverses heart disease—and was found by parents”.*
more

Meridian Lab Announced Positive Outcome from Pre-NDA Meeting with FDA

News 1 February, 2016
Meridian Labs is a specialty pharmaceutical company focusing on the development of cancer treatments through formulation improvements.
more

Cyclodextrins on the Cover of Nature

News 1 February, 2016
Novel porous βCD polymer was prepared and used for rapid removal of organic micropollutants from water. The crosslinking agent, tetrafluoroterephthalonitrile ensures rigid structure and high porosity improving the availability of the CD rings within the structure.
more

Breakthrough Therapy designation to HPBCD of Vtesse

News 1 February, 2016
Vtesse, Inc, a rare disease company, announced that FDA granted Breakthrough Therapy designation to VTS-270 (a proprietary form of HPBCD) for the treatment of children with Niemann-Pick Disease Type C (NPC).
more

SBEBCD for FDA-Approved Cannabinoid-based Medications

News 1 February, 2016
Virio Health, LLC announced that it has entered into exclusive license and supply agreement with Ligand Pharmaceuticals, Inc. for Captisol to be used for the development of cannabinoid-based medications.
more

Events

Conference attendance in August and September

Events 23 August, 2017
Cyclolab's staff will attend quite a few important meetings in the coming weeks and deliver talks and posters on hot topics in connection with cyclodextrin applications. Please, let us know if you are interested to meet us and discuss potential collaboration.
more

CycloLab at the Drug Discovery and Therapy World Congress - 2017

Events 2 August, 2017
The Drug Discovery and Therapy World Congress 2017 was held between 10-13th July, 2017 in Boston, USA.
more

CycloLab at BIT's 7th Annual SDDS - 2017

Events 19 July, 2017
The 7th Annual International Symposium of Drug Delivery Systems was held on 12-14 July, 2017 in Prague, Czech Republic.
more